1403 A bispecific antibody targeting PD1 and CD40 displays potent anti-tumor efficacy through two mechanisms: PD1 blockade and PD1-dependent CD40 agonism
Journal for ImmunoTherapy of Cancer（2023）
关键词
bispecific antibody,pd1 blockade,cd40 displays,anti-tumor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要